Global Clinical Nutrition Market: Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2012-2016 and Forecast 2017-2023

November 2017 | 201 pages | ID: GD028F16F5FEN
Precision Business Insights (PBI)

Abstracts

Global Clinical Nutrition Market:

Global clinical nutrition market estimated to be valued US$ XX Mn in 2017 and poised to grow at CAGR of XX% over 2017-2023. Market for clinical nutrition products is projected to reach US$ XX Mn by 2023.

Clinical nutrition is the basic knowledge of treatment and diagnosis of disease which affects the intestinal absorption, metabolism and intake of constituents of diet, and to t promotion of health by preventing diet-related diseases. Clinical nutrition products are a kind of pharmaceutical products which help in keeping the patient healthy. Clinical nutrition products also helps in improving the metabolic system of body by providing optimal amounts of supplements like vitamins, minerals etc. Clinical nutrition products improve digestion, absorption, and metabolism, storage of nutrients, transportation, and discharge of waste from the human body.

The global market for clinical nutrition is propelling owing to the growing geriatric population who are highly prone to the major health issues related to the metabolic disorders & loss of appetite. Increase in initiatives taken by the governments, Malnutrition, rise in junk foods intake, poverty, lack in awareness are the factors that are fuelling the growth of clinical nutrition market growth. However, strict government regulations, low reimbursement policies, volatility of the market, patient compliance complexities are the factors hampering the market growth.

Clinical nutrition Market is segmented on the basis of product type, disease conditions, and route of administration, distribution channel, and region.

On the basis of product type, clinical nutrition market is segmented as:

• Vitamins and Minerals
• Pre/Probiotic
• Amino Acids
• Glucose
• Lipids
• Omega Fatty Acids
• Others

On the basis of medical conditions, clinical nutrition market is segmented as:

• Metabolic Disorders
• Neurological Disorders
• Gastrointestinal Disorders
• Eating Disorders
• Others

On the basis of route of administration, clinical nutrition market is segmented as:

• Oral
• Enteral
• Parenteral

On the basis of distribution channel, clinical nutrition market is segmented as:

• Hospital Pharmacies
• Retail Pharmacies
• Others

The progressive impact of growing population pool of baby boomers is protruded to remain as an intermediate in coming years as expectancy of life is expected to increase due to improvement of standards of health. Rise in the incidence rate of chronic diseases like diabetes, cancer, and HIV/AIDS is driving the global clinical nutrition market growth. In paediatric category, increasing demand for the clinical nutrition is emerged as budding opportunity for market of the clinical nutrition. Growing home care use of nutritional products is anticipated to increase demand for the clinical nutrition market.

Based on geographical region, the global clinical nutrition market is segmented as Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. Asia- Pacific is dominating the global market of clinical nutritional products. Owing to the high birth rate in countries like India and China are expected to drive the demand for the clinical nutrition products, especially for infant nutrition products. As per the World Bank Group, India has highest birth-rate in APAC region in 2012. In Europe, France and UK have highest birth rate in same year. North America and the Europe are anticipated to dominate global clinical nutrition products market during the forecast period owing the rising investments from the manufacturers in R&D for the innovation of novel products with enhancement of nutrition.

Some of the players in clinical nutrition market are Ajinomoto Co. Inc., Perrigo Company Plc Abbott Nutrition Inc., Baxter International Inc., Danon Baby and Medical Nutrition BV, B. Braun Medical Inc., Fresenius Kabi AG, Hospira (Pfizer) Inc., Gentiva Health Services Inc., Hero Nutritional Inc., and Nestle SA.

In April 2012, Nestle acquired Pfizer Nutrition to increase its position in infant nutrition market globally

In March 2014, Perrigo Company plc and KanPak LLC entered into partnership for manufacturing adult nutritional drinks

In April 2016, Perrigo Company plc, launched Glucerna aseptic nutritional shake for diabetic people

In July 2017, Perrigo Company plc received U.S. FDA approval of AB rated ANDA referencing DermOtic Oil Ear Drops

REPORT OUTLINE:

• The report provides granular level information about the market size, regional market share and forecast from 2017-2023
• The report covers in-detail insights about the competitor’s overview, key findings and their key strategies
• The Report Outlines drivers, restraints, challenges, and trends that are currently faced by the industry
• The report tracks recent innovations, key developments and startup’s details that are working in the industry
• The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario

Contents

1. EXECUTIVE SUMMARY

2. GLOBAL CLINICAL NUTRITION MARKET INTRODUCTION

2.1. Global Clinical Nutrition Market – Taxonomy
2.2. Global Clinical Nutrition Market –Definitions
  2.2.1. Product Type
  2.2.2. Application
  2.2.3. End-User

3. GLOBAL CLINICAL NUTRITION MARKET DYNAMICS

3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Global Clinical Nutrition Market Dynamics – Factors Impact Analysis
3.6. Global Clinical Nutrition Market – Regulations
  3.6.1. U.S
  3.6.2. Europe
  3.6.3. Japan
3.7. Global Clinical Nutrition Market – Recent Product Innovations

4. GLOBAL CLINICAL NUTRITION MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 – 2023

4.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
4.3. Market Oppurtunity Analysis

5. GLOBAL CLINICAL NUTRITION MARKET, BY PRODUCT TYPE, 2012 - 2016 AND FORECAST, 2017 - 2023

5.1. Vitamins and Minerals
  5.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  5.1.3. Market Opportunity Analysis
5.2. Pre/Probiotic
  5.2.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  5.2.3. Market Opportunity Analysis
5.3. Amino Acids
  5.3.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  5.3.3. Market Opportunity Analysis
5.4. Glucose
  5.4.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  5.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  5.4.3. Market Opportunity Analysis
5.5. Lipids
  5.5.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  5.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  5.5.3. Market Opportunity Analysis
5.6. Omega Fatty Acids
  5.6.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  5.6.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  5.6.3. Market Opportunity Analysis
5.7. Others
  5.7.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  5.7.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  5.7.3. Market Opportunity Analysis

6. GLOBAL CLINICAL NUTRITION MARKET, BY MEDICAL CONDITION, 2012 - 2016 AND FORECAST, 2017 - 2023

6.1. Metabolic Disorders
  6.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  6.1.3. Market Opportunity Analysis
6.2. Neurological Disorders
  6.2.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  6.2.3. Market Opportunity Analysis
6.3. Gastrointestinal Disorders
  6.3.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  6.3.3. Market Opportunity Analysis
6.4. Eating Disorders
  6.4.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  6.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  6.4.3. Market Opportunity Analysis
6.5. Others
  6.5.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  6.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  6.5.3. Market Opportunity Analysis

7. GLOBAL CLINICAL NUTRITION MARKET FORECAST, BY ROUTE OF ADMINISTRATION, 2012 - 2016 AND FORECAST, 2017 - 2023

7.1. Oral
  7.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  7.1.3. Market Opportunity Analysis
7.2. Enteral
  7.2.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  7.2.3. Market Opportunity Analysis
7.3. Parenteral
  7.3.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  7.3.3. Market Opportunity Analysis

8. GLOBAL CLINICAL NUTRITION MARKET FORECAST, BY DISTRIBUTION CHANNEL, 2012 - 2016 AND FORECAST, 2017 - 2023

8.1. Hospital Pharmacies
  8.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  8.1.3. Market Opportunity Analysis
8.2. Retail Pharmacies
  8.2.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  8.2.3. Market Opportunity Analysis
8.3. Others
  8.3.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  8.3.3. Market Opportunity Analysis

9. GLOBAL CLINICAL NUTRITION MARKET FORECAST, BY REGION, 2012 - 2016 AND FORECAST, 2017 - 2023

9.1. North America
  9.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  9.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  9.1.3. Market Opportunity Analysis
9.2. Europe
  9.2.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  9.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  9.2.3. Market Opportunity Analysis
9.3. Asia-Pacific
  9.3.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  9.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  9.3.3. Market Opportunity Analysis
9.4. Latin America
  9.4.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  9.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  9.4.3. Market Opportunity Analysis
9.5. Middle East and Africa
  9.5.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  9.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  9.5.3. Market Opportunity Analysis
9.6. Global Clinical Nutrition Market - Opportunity Analysis Index, By Product Type, medical condition, route of administration, distribution channel and Region, 2017 – 2023

10. NORTH AMERICA CLINICAL NUTRITION MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 - 2023

  10.1.1. Product Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
    10.1.1.1. Vitamins and Minerals
    10.1.1.2. Pre/Probiotic
    10.1.1.3. Amino Acids
    10.1.1.4. Glucose
    10.1.1.5. Lipids
    10.1.1.6. Omega Fatty Acids
    10.1.1.7. Others
  10.1.2. Medical condition Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
    10.1.2.1. Metabolic Disorders
    10.1.2.2. Neurological Disorders
    10.1.2.3. Gastrointestinal Disorders
    10.1.2.4. Eating Disorders
    10.1.2.5. Others
  10.1.3. Route of Administration Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
    10.1.3.1. Oral
    10.1.3.2. Enteral
    10.1.3.3. Parenteral
  10.1.4. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
    10.1.4.1. U.S.
    10.1.4.2. Canada
  10.1.5. North America Clinical Nutrition Market - Opportunity Analysis Index, By Product Type, Medical condition, Route of administration, Distribution channel and Country, 2017 – 2023
  10.1.6. North America Clinical Nutrition Market Dynamics – Trends

11. EUROPE CLINICAL NUTRITION MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 - 2023

  11.1.1. Product Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
    11.1.1.1. Vitamins and Minerals
    11.1.1.2. Pre/Probiotic
    11.1.1.3. Amino Acids
    11.1.1.4. Glucose
    11.1.1.5. Lipids
    11.1.1.6. Omega Fatty Acids
    11.1.1.7. Others
  11.1.2. Medical condition Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
    11.1.2.1. Metabolic Disorders
    11.1.2.2. Neurological Disorders
    11.1.2.3. Gastrointestinal Disorders
    11.1.2.4. Eating Disorders
    11.1.2.5. Others
  11.1.3. Route of Administration Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
    11.1.3.1. Oral
    11.1.3.2. Enteral
    11.1.3.3. Parenteral
  11.1.4. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
    11.1.4.1. Germany
    11.1.4.2. UK
    11.1.4.3. France
    11.1.4.4. Spain
    11.1.4.5. Italy
    11.1.4.6. Russia
    11.1.4.7. Poland
    11.1.4.8. Rest of Europe
  11.1.5. Europe Clinical Nutrition Market - By Product Type, Medical condition, Route of administration, Distribution channel and Country, 2017 – 2023
  11.1.6. Europe Clinical Nutrition Market Dynamics – Trends

12. ASIA-PACIFIC CLINICAL NUTRITION MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 - 2023

  12.1.1. Product Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
    12.1.1.1. Vitamins and Minerals
    12.1.1.2. Pre/Probiotic
    12.1.1.3. Amino Acids
    12.1.1.4. Glucose
    12.1.1.5. Lipids
    12.1.1.6. Omega Fatty Acids
    12.1.1.7. Others
  12.1.2. Medical condition Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
    12.1.2.1. Metabolic Disorders
    12.1.2.2. Neurological Disorders
    12.1.2.3. Gastrointestinal Disorders
    12.1.2.4. Eating Disorders
    12.1.2.5. Others
  12.1.3. Route of Administration Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
    12.1.3.1. Oral
    12.1.3.2. Enteral
    12.1.3.3. Parenteral
  12.1.4. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn),
Y-o-Y Growth (%), and Market Share (%)
    12.1.4.1. Japan
    12.1.4.2. China
    12.1.4.3. India
    12.1.4.4. ASEAN
    12.1.4.5. Australia & New Zealand
    12.1.4.6. Rest of Asia-Pacific
  12.1.5. Asia-Pacific Clinical Nutrition Market - Opportunity Analysis Index, By Product Type, Medical condition, Route of administration, Distribution channel and Country, 2017 – 2023
  12.1.6. Asia-Pacific Clinical Nutrition Market Dynamics – Trends

13. LATIN AMERICA CLINICAL NUTRITION MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 - 2023

  13.1.1. Product Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
    13.1.1.1. Vitamins and Minerals
    13.1.1.2. Pre/Probiotic
    13.1.1.3. Amino Acids
    13.1.1.4. Glucose
    13.1.1.5. Lipids
    13.1.1.6. Omega Fatty Acids
    13.1.1.7. Others
  13.1.2. Medical condition Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
    13.1.2.1. Metabolic Disorders
    13.1.2.2. Neurological Disorders
    13.1.2.3. Gastrointestinal Disorders
    13.1.2.4. Eating Disorders
    13.1.2.5. Others
  13.1.3. Route of Administration Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
    13.1.3.1. Oral
    13.1.3.2. Enteral
    13.1.3.3. Parenteral
  13.1.4. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
    13.1.4.1. Brazil
    13.1.4.2. Mexico
    13.1.4.3. Argentina
    13.1.4.4. Venezuela
    13.1.4.5. Rest of Latin America
  13.1.5. Latin America Clinical Nutrition Market - Opportunity Analysis Index, By Product Type, Medical condition, Route of administration, Distribution channel and Country, 2017 – 2023
  13.1.6. Latin America Clinical Nutrition Market Dynamics – Trends

14. MIDDLE EAST AND AFRICA CLINICAL NUTRITION MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 - 2023

  14.1.1. Product Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
    14.1.1.1. Vitamins and Minerals
    14.1.1.2. Pre/Probiotic
    14.1.1.3. Amino Acids
    14.1.1.4. Glucose
    14.1.1.5. Lipids
    14.1.1.6. Omega Fatty Acids
    14.1.1.7. Others
  14.1.2. Medical condition Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
    14.1.2.1. Metabolic Disorders
    14.1.2.2. Neurological Disorders
    14.1.2.3. Gastrointestinal Disorders
    14.1.2.4. Eating Disorders
    14.1.2.5. Others
  14.1.3. Route of Administration Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
    14.1.3.1. Oral
    14.1.3.2. Enteral
    14.1.3.3. Parenteral
  14.1.4. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
    14.1.4.1. Gulf Cooperation Council (GCC) Countries
    14.1.4.2. Israel
    14.1.4.3. South Africa
    14.1.4.4. Rest of MEA
  14.1.5. MEA Clinical Nutrition Market - Opportunity Analysis Index, Opportunity Analysis Index, By Product Type, Medical condition, Route of administration, Distribution channel and Country, 2017 – 2023
  14.1.6. MEA Clinical Nutrition Market Dynamics – Trends

15. COMPETITION LANDSCAPE

15.1. Strategic Dashboard of Top Market Players
15.2. Company Profiles (Introduction, Financial Analysis, Product & Service Offerings, Key Developments, Strategies, and SWOT Analysis)
  15.2.1. Ajinomoto Co. Inc.
  15.2.2. Perrigo Company Plc
  15.2.3. Abbott Laboratories
  15.2.4. Baxter International Inc.
  15.2.5. Danon Baby and Medical Nutrition BV
  15.2.6. B. Braun Medical Inc.
  15.2.7. Fresenius Kabi AG
  15.2.8. Hospira (Pfizer) Inc.
  15.2.9. Gentiva Health Services Inc.
  15.2.10. Hero Nutritional Inc.
  15.2.11. Nestle SA.

16. RESEARCH METHODOLOGY

Key Assumptions and Acronyms